Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

383 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Association of galectin-3 and fibrosis markers with long-term cardiovascular outcomes in patients with heart failure, left ventricular dysfunction, and dyssynchrony: insights from the CARE-HF (Cardiac Resynchronization in Heart Failure) trial.
Lopez-Andrès N, Rossignol P, Iraqi W, Fay R, Nuée J, Ghio S, Cleland JG, Zannad F, Lacolley P. Lopez-Andrès N, et al. Among authors: fay r. Eur J Heart Fail. 2012 Jan;14(1):74-81. doi: 10.1093/eurjhf/hfr151. Epub 2011 Nov 16. Eur J Heart Fail. 2012. PMID: 22089058 Free article. Clinical Trial.
Extracellular cardiac matrix biomarkers in patients with acute myocardial infarction complicated by left ventricular dysfunction and heart failure: insights from the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS) study.
Iraqi W, Rossignol P, Angioi M, Fay R, Nuée J, Ketelslegers JM, Vincent J, Pitt B, Zannad F. Iraqi W, et al. Among authors: fay r. Circulation. 2009 May 12;119(18):2471-9. doi: 10.1161/CIRCULATIONAHA.108.809194. Epub 2009 Apr 27. Circulation. 2009. PMID: 19398668 Clinical Trial.
Timing of eplerenone initiation and outcomes in patients with heart failure after acute myocardial infarction complicated by left ventricular systolic dysfunction: insights from the EPHESUS trial.
Adamopoulos C, Ahmed A, Fay R, Angioi M, Filippatos G, Vincent J, Pitt B, Zannad F; EPHESUS Investigators. Adamopoulos C, et al. Among authors: fay r. Eur J Heart Fail. 2009 Nov;11(11):1099-105. doi: 10.1093/eurjhf/hfp136. Eur J Heart Fail. 2009. PMID: 19875410 Free PMC article. Clinical Trial.
Impact of eplerenone on cardiovascular outcomes in heart failure patients with hypokalaemia.
Rossignol P, Girerd N, Bakris G, Vardeny O, Claggett B, McMurray JJV, Swedberg K, Krum H, van Veldhuisen DJ, Shi H, Spanyers S, Vincent J, Fay R, Lamiral Z, Solomon SD, Zannad F, Pitt B. Rossignol P, et al. Among authors: fay r. Eur J Heart Fail. 2017 Jun;19(6):792-799. doi: 10.1002/ejhf.688. Epub 2016 Nov 20. Eur J Heart Fail. 2017. PMID: 27868385 Free article. Clinical Trial.
Association of digitalis treatment with outcomes following myocardial infarction in patients with heart failure or evidence of left ventricular dysfunction: an analysis from the High-Risk Myocardial Infarction Database Initiative.
Coiro S, Girerd N, Rossignol P, Bauersachs J, Pitt B, Fay R, Ambrosio G, Solomon SD, Dickstein K, Zannad F. Coiro S, et al. Among authors: fay r. Clin Res Cardiol. 2017 Sep;106(9):722-733. doi: 10.1007/s00392-017-1116-z. Epub 2017 Apr 28. Clin Res Cardiol. 2017. PMID: 28455597
Eplerenone survival benefits in heart failure patients post-myocardial infarction are independent from its diuretic and potassium-sparing effects. Insights from an EPHESUS (Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study) substudy.
Rossignol P, Ménard J, Fay R, Gustafsson F, Pitt B, Zannad F. Rossignol P, et al. Among authors: fay r. J Am Coll Cardiol. 2011 Nov 1;58(19):1958-66. doi: 10.1016/j.jacc.2011.04.049. J Am Coll Cardiol. 2011. PMID: 22032706 Free article.
383 results